Bioequivalence and Safety of Vantobra and TOBI in Healthy Subjects

NCT01953367 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Vantobra (tobramycin)
DRUG: TOBI (tobramycin)

Sponsor

Pari Pharma GmbH